Philips debuts two new cardio products to European market at London conference

Philips ($PHG) used this year's European Society of Cardiology Congress meeting in London to announce the European debut of two new cardio products--HeartMode A.I. and IntelliSpace Cardiovascular.

HeartModel is an Anatomically Intelligent Ultrasound (AIUS) device that improves quantification and provides automated 3-D images with better reproducible ultrasound results and faster exam times, the company said. Exams with HeartModel are reported three to 6 times faster than conventional 2-D exams in gathering left ventricular and atrial dimensions as well as volumes.

The technology is part of the EPIQ 7 ultrasound systems.

"Collecting heart measurements in 3-D is difficult and time consuming," Jose Aamorana of the University Hospital Ramón y Cajal in Madrid, said in a statement. "HeartModel helps to make collecting critical cardiac ultrasound measurements easier and more reproducible, which will not only enable time savings, but will hopefully extend the adoption of 3-D echocardiography exams to more clinicians."

Additionally, the Dutch conglomerate showcased its IntelliSpace Cardiovascular product, which is a web-enabled image and information management system. IntelliSpace can create and store a digital cardiovascular image database and develop algorithms to enable more personalized patient care. The system also has the ability to access other third-party applications.

The European Society of Cardiology conference is considered one of the largest and most influential cardiology events in the world.

- see the HeartModel release
- check out the IntelliSpace release

Suggested Articles

The two companies also plan to identify new potential targets and therapeutic candidates for inflammatory bowel disease, or IBD.

This would allow centralized, lab-based diagnostic hardware to process blood samples at scale, screening patients for previous infections.

GlaxoSmithKline and AstraZeneca are considering forming a joint lab to help the U.K. expand its supplies for COVID-19 testing, according to Bloomberg.